Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
A Gastronomic Experience in Healthy Enjoyments: A Survey of \Nutritious and Tasty\ Solid Cooking Recipe Book - 2Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips
- 3FDA updates risk classification for voluntary shredded cheese recall
- 4Inside The Design-Forward Wellness Hotel Marking A New Chapter In Medellín
- 5The Manual for Decent European Urban communities in 2024
- Hidden Island Cameras Capture Rare Tasmanian Species for the First Time Ever
- Progress Over Perfection: Lessons From Garment Factories Fighting Heat Stress
- A somber Thor is returning for 'Avengers: Doomsday': Watch the dread-filled teaser
- What's your biological age? Experts explain the benefits and risks of at-home tests
- In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
- Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
- Merz: 80% of Syrians in Germany expected to return within three years
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
